Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
Acquired_by_PerkinElmer
|
| gptkbp:awards |
Best Company to Work For (2020)
Best_Biotechnology_Company_(2019) |
| gptkbp:communityEngagement |
educational programs
outreach initiatives partnerships with universities |
| gptkbp:competitors |
gptkb:Agilent_Technologies
gptkb:Editas_Medicine gptkb:Thermo_Fisher_Scientific gptkb:Sangamo_Therapeutics Illumina |
| gptkbp:employees |
200+
|
| gptkbp:events |
scientific symposiums
biotechnology conferences investor meetings |
| gptkbp:founded |
2007
|
| gptkbp:founder |
gptkb:Darrin_Disley
|
| gptkbp:headquarters |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Horizon Discovery Group plc
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:investmentFocus |
Institutional investors
Venture capitalists Private equity firms |
| gptkbp:keyPeople |
gptkb:Katherine_Stoecklein
gptkb:Darrin_Disley Terry_Pizzie |
| gptkbp:location |
gptkb:Cambridge
|
| gptkbp:market |
global
|
| gptkbp:partnerships |
collaborations with pharmaceutical companies
|
| gptkbp:patentCitation |
gene editing technologies
cell line engineering genetic modification methods |
| gptkbp:products |
gene editing tools
|
| gptkbp:publications |
research papers
scientific journals patent filings |
| gptkbp:researchFocus |
genomics
|
| gptkbp:revenue |
£30 million (2020)
|
| gptkbp:services |
genetic engineering
|
| gptkbp:specialization |
cell line development
|
| gptkbp:stockSymbol |
HZD
|
| gptkbp:subsidiary |
gptkb:Horizon_Discovery_(US)_Inc.
gptkb:Horizon_Discovery_(UK)_Ltd. |
| gptkbp:technology |
RNA interference
CRISPR gene synthesis |
| gptkbp:type |
public company
|
| gptkbp:website |
www.horizondiscovery.com
|